The biggest news of the weekend was the Saturday revelation that the work Yale University has been doing to test saliva-based tests for COVID-19 has borne fruit. The testing, funded by the NBA and NBPA and tested by the league and most teams in the Orlando bubble, is able to generate the same results as the nasal swab test so effectively that the failure rate is statistically insignificant.
This has not yet been peer-reviewed, which could be an issue, but the success rate was enough for the FDA to lend its emergency approval to the test. Its advantages over the nasal swab are obvious, but it’s the financial story that is the big news for Americans.